Fourth and final issue of GaBI Journal’s third volume
Availability and procurement of generics in hospitals among medium-sized European countries
Access to alternative biopharmaceuticals in low- and middle- income countries
Biosimilars versus ‘biobetters’ — a regulator’s perspective
Safety assessment of biosimilars in Europe: a regulatory perspective
Is Australia positioned to take advantage of biosimilars?
Regulation of biologicals in Malaysia
2014 World Transplant Congress, San Francisco, California, USA, 26–31 July 2014
Amgen’s move into the biosimilars market
International Alliance of Patients’ Organizations toolkit for biological and biosimilar medicines
Reducing the European healthcare budget with generics and biosimilars
Pharmaceutical policy interventions in times of economic recession
Source URL: https://gabi-journal.net/20144-gabi-journal-table-of-contents.html
Copyright ©2024 GaBI Journal unless otherwise noted.